Canine Osteosarcoma Trial

ETHOS VETERINARY HEALTH AND ETHOS DISCOVERY ARE INVESTIGATING A POTENTIAL TREATMENT FOR CANINE OSTEOSARCOMA (OSA)



Canine Osteosarcoma Trial

CURRENTLY ENROLLING

The Objective of This Study: is to determine whether or not canine patients diagnosed with canine osteosarcoma (OSA) have intestinal dysbiosis, and whether treating intestinal disease improves patient outcomes.


We Seek to Understand: the link between the gut biome, specifically intestinal dysbiosis, in dogs with OSA. Osteosarcoma is a malignant bone cancer typically found in the long bones (arms and legs).


PARTICIPATION IN THIS STUDY IS FREE



Intestinal dysbiosis is a broad term that is defined as the imbalance of gut microbiota associated with an unhealthy outcome. In human patients intestinal dysbiosis has been associated with tumor progression of colorectal, lung, and breast cancer.


To date, no studies have been published investigating the relationship between the intestinal microbiome in dogs or humans with osteosarcoma (OSA). If your dog has been recently diagnosed with osteosarcoma we welcome your participation in our study.


WE NEED YOUR HELP

We Are Looking for a Rare Subset of Patients

How Can You Help?

Send a Stool Sample

  • Any eligible patient can participate in this study.
  • The patient must have a biopsy result confirming the diagnosis (with or without evidence of metastasis).
  • Contact us to confirm eligibility and we'll send you a mailing kit

Is Your Pet Eligible?

If your dog has been diagnosed with osteosarcoma, you may be eligible to participate in this trial. If you are interested, please fill out the form below. Our expert team of veterinarians will be in touch to confirm eligibility and discuss next steps.

Spotlight

Ethos Discovery

Ethos Discovery is a 501(c)3 non-profit dedicated to conducting scientific research.


It is our hope that our research and clinical studies will pave the way for innovative diagnostic and treatment options that lead to a cure for complex medical conditions such as cancer. We are agnostic to the source of good ideas and invite all innovators to join us in our work.


Eligible patients with naturally occurring disease are encouraged to participate in our studies. Our highly innovative science portfolio exists thanks to like-minded veterinarians, veterinary technicians, specialists and other members of Ethos and the veterinary industry.



Our Studies